Note: Ingredients listed on restricted chemical lists
EC/CAS
278-355-8/75980-60-8
Name of the chemical
Diphenyl(2,4,6-trimethylbenzoyl)phosphinoxid
Concentration
12
General Information
Version
2.0
Revision date
2022-05-19
Product name
Rubio Monocoat Oil UV - comp. B
Icons in SDS
Company Information
company name
Muylle Facon B.V
e-mail address of the competent person responsible for the Safety Data Sheet
info@rubiomonocoat.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H361, H412
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS07 GHS08
Signal word
Warning
Contains
diphenyl(2,4,6-trimethylbenzoyl)phosphineoxide, 2-hydroxy-2-methylpropiophenone
Hazard statements
H302 - Harmful if swallowed. H361 - Suspected of damaging fertility or the unborn child. H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
P102 - Keep out of reach of children. P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P273 - Avoid release to the environment.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component 2-hydroxy-2-methylpropiophenone (7473-98-5) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %